Your browser doesn't support javascript.
loading
Does neurokinin-1-receptor antagonist aprepitant diminish the efficacy of cyclophosphamide-based chemotherapy?: [letter to the editor] / O antagonista do receptor de neuroquinina-1 aprepitante diminui a eficácia da quimioterapia baseada em ciclofosfamida?: [carta ao editor]
Paiva, Carlos Eduardo; Paiva, Bianca Sakamoto Ribeiro; Michelin, Odair Carlito.
Affiliation
  • Paiva, Carlos Eduardo; Universidade Estadual Paulista. Oncological and Hemato-Oncological Center. Botucatu. BR
  • Paiva, Bianca Sakamoto Ribeiro; Universidade Estadual Paulista. Botucatu Medical School. Department of Nursing. Botucatu. BR
  • Michelin, Odair Carlito; Universidade Estadual Paulista. Botucatu Medical School. Department of Clinics. Botucatu. BR
São Paulo med. j ; 127(6): 385-386, Nov. 2009.
Article в En | LILACS | ID: lil-547349
Ответственная библиотека: BR1.1
Полный текст: 1 База данных: LILACS Основная тема: Morpholines / Receptors, Neurokinin-1 / Antineoplastic Agents, Alkylating / Cyclophosphamide / Antiemetics Пределы темы: Female / Humans Язык: En Журнал: São Paulo med. j Тематика журнала: Cirurgia Geral / Ciˆncia / Ginecologia / MEDICINA / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Год: 2009 Тип: Article
Полный текст: 1 База данных: LILACS Основная тема: Morpholines / Receptors, Neurokinin-1 / Antineoplastic Agents, Alkylating / Cyclophosphamide / Antiemetics Пределы темы: Female / Humans Язык: En Журнал: São Paulo med. j Тематика журнала: Cirurgia Geral / Ciˆncia / Ginecologia / MEDICINA / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Год: 2009 Тип: Article